Robert Joseph Thomas, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Sleep Apnea, Obstructive | 38 | 2023 | 1898 | 4.570 |
Why?
|
Polysomnography | 55 | 2024 | 1871 | 4.500 |
Why?
|
Sleep Apnea Syndromes | 26 | 2022 | 984 | 4.360 |
Why?
|
Continuous Positive Airway Pressure | 16 | 2023 | 580 | 3.610 |
Why?
|
Sleep Stages | 21 | 2024 | 706 | 2.480 |
Why?
|
Sleep | 30 | 2024 | 4820 | 2.310 |
Why?
|
Sleep Apnea, Central | 5 | 2015 | 88 | 1.570 |
Why?
|
Disorders of Excessive Somnolence | 6 | 2024 | 279 | 1.550 |
Why?
|
Electroencephalography | 23 | 2024 | 6318 | 1.090 |
Why?
|
Electrocardiography | 15 | 2020 | 6413 | 1.090 |
Why?
|
Arousal | 12 | 2019 | 1183 | 1.080 |
Why?
|
Acetazolamide | 3 | 2021 | 98 | 0.910 |
Why?
|
Sleep Medicine Specialty | 2 | 2014 | 72 | 0.860 |
Why?
|
Respiration | 7 | 2023 | 1668 | 0.860 |
Why?
|
Sleep Deprivation | 7 | 2024 | 848 | 0.850 |
Why?
|
Narcolepsy | 2 | 2020 | 200 | 0.790 |
Why?
|
Sleep, REM | 10 | 2024 | 595 | 0.790 |
Why?
|
Sleep Disorders, Circadian Rhythm | 2 | 2019 | 197 | 0.730 |
Why?
|
Heart Rate | 9 | 2017 | 4217 | 0.720 |
Why?
|
Hypercapnia | 3 | 2016 | 260 | 0.640 |
Why?
|
Positive-Pressure Respiration | 5 | 2018 | 713 | 0.630 |
Why?
|
Friedreich Ataxia | 1 | 2019 | 82 | 0.620 |
Why?
|
Respiratory Dead Space | 2 | 2010 | 31 | 0.610 |
Why?
|
Chronobiology Disorders | 1 | 2019 | 73 | 0.610 |
Why?
|
Restless Legs Syndrome | 2 | 2019 | 235 | 0.610 |
Why?
|
Signal Processing, Computer-Assisted | 6 | 2016 | 1495 | 0.580 |
Why?
|
Sleep Initiation and Maintenance Disorders | 5 | 2024 | 1106 | 0.570 |
Why?
|
Pulmonary Ventilation | 2 | 2018 | 375 | 0.550 |
Why?
|
Brain | 16 | 2024 | 27476 | 0.550 |
Why?
|
Respiratory System | 2 | 2018 | 565 | 0.540 |
Why?
|
Electrocardiography, Ambulatory | 2 | 2011 | 582 | 0.530 |
Why?
|
Severity of Illness Index | 22 | 2018 | 15955 | 0.520 |
Why?
|
Fibromyalgia | 2 | 2011 | 407 | 0.520 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 2 | 2017 | 251 | 0.510 |
Why?
|
Eligibility Determination | 1 | 2019 | 421 | 0.500 |
Why?
|
Memory, Short-Term | 3 | 2014 | 1010 | 0.470 |
Why?
|
Uncertainty | 1 | 2019 | 769 | 0.450 |
Why?
|
Benzhydryl Compounds | 2 | 2014 | 943 | 0.440 |
Why?
|
Hypocapnia | 2 | 2010 | 38 | 0.430 |
Why?
|
Apnea | 1 | 2014 | 195 | 0.420 |
Why?
|
Dyssomnias | 2 | 2009 | 28 | 0.410 |
Why?
|
Dementia | 5 | 2024 | 2741 | 0.400 |
Why?
|
Humans | 115 | 2024 | 768887 | 0.400 |
Why?
|
Amyloid | 1 | 2017 | 854 | 0.380 |
Why?
|
Amitriptyline | 1 | 2011 | 112 | 0.380 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2014 | 390 | 0.370 |
Why?
|
Pulse | 1 | 2011 | 218 | 0.370 |
Why?
|
Automobile Driving | 1 | 2016 | 442 | 0.360 |
Why?
|
Carbon Dioxide | 2 | 2005 | 1149 | 0.360 |
Why?
|
Male | 70 | 2024 | 365249 | 0.360 |
Why?
|
Cerebral Cortex | 5 | 2014 | 5834 | 0.350 |
Why?
|
Middle Aged | 53 | 2024 | 223740 | 0.340 |
Why?
|
Oxygen Inhalation Therapy | 2 | 2010 | 417 | 0.330 |
Why?
|
Circadian Rhythm | 5 | 2023 | 2593 | 0.330 |
Why?
|
Cell Culture Techniques | 2 | 2014 | 1667 | 0.310 |
Why?
|
Biological Clocks | 1 | 2011 | 321 | 0.310 |
Why?
|
Female | 59 | 2024 | 397464 | 0.290 |
Why?
|
Expert Systems | 1 | 2007 | 79 | 0.290 |
Why?
|
Memory | 3 | 2017 | 2210 | 0.290 |
Why?
|
Ambulatory Care | 1 | 2018 | 2783 | 0.280 |
Why?
|
Placebos | 1 | 2011 | 1668 | 0.280 |
Why?
|
Respiratory Mechanics | 2 | 2011 | 722 | 0.280 |
Why?
|
Republic of Korea | 7 | 2019 | 592 | 0.280 |
Why?
|
Hypertension | 5 | 2018 | 8615 | 0.280 |
Why?
|
Respiration, Artificial | 1 | 2018 | 2724 | 0.280 |
Why?
|
Brain Ischemia | 1 | 2019 | 3008 | 0.260 |
Why?
|
Periodicity | 1 | 2007 | 348 | 0.250 |
Why?
|
Mental Fatigue | 1 | 2005 | 23 | 0.250 |
Why?
|
Embryonic Stem Cells | 1 | 2013 | 1251 | 0.250 |
Why?
|
Aged | 35 | 2024 | 171790 | 0.240 |
Why?
|
Adult | 41 | 2024 | 223818 | 0.240 |
Why?
|
Stroke | 3 | 2019 | 9756 | 0.240 |
Why?
|
Brain Waves | 2 | 2023 | 418 | 0.230 |
Why?
|
Models, Statistical | 1 | 2019 | 5107 | 0.230 |
Why?
|
Magnetic Resonance Imaging | 12 | 2019 | 36861 | 0.230 |
Why?
|
Tai Ji | 1 | 2007 | 291 | 0.220 |
Why?
|
Fourier Analysis | 4 | 2015 | 441 | 0.220 |
Why?
|
Heart Failure | 3 | 2019 | 11879 | 0.210 |
Why?
|
Neuroanatomy | 1 | 2003 | 73 | 0.210 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2007 | 709 | 0.200 |
Why?
|
REM Sleep Behavior Disorder | 1 | 2023 | 111 | 0.200 |
Why?
|
Fatigue | 2 | 2023 | 1557 | 0.200 |
Why?
|
Magnetoencephalography | 2 | 2019 | 642 | 0.200 |
Why?
|
Prefrontal Cortex | 2 | 2019 | 2257 | 0.190 |
Why?
|
Brain Mapping | 3 | 2006 | 6740 | 0.190 |
Why?
|
Biomedical Research | 1 | 2017 | 3463 | 0.190 |
Why?
|
Insurance, Health | 1 | 2013 | 2518 | 0.180 |
Why?
|
Respiratory Rate | 2 | 2021 | 180 | 0.180 |
Why?
|
Carbonic Anhydrase Inhibitors | 1 | 2021 | 92 | 0.180 |
Why?
|
Patient Compliance | 1 | 2011 | 2701 | 0.180 |
Why?
|
Reproducibility of Results | 5 | 2024 | 20244 | 0.180 |
Why?
|
Depressive Disorder, Major | 2 | 2011 | 4819 | 0.180 |
Why?
|
Psychomotor Performance | 3 | 2014 | 1895 | 0.170 |
Why?
|
Acoustic Stimulation | 1 | 2024 | 1256 | 0.170 |
Why?
|
Glucose | 1 | 2012 | 4352 | 0.170 |
Why?
|
Neuropsychological Tests | 4 | 2017 | 7148 | 0.170 |
Why?
|
Wakefulness | 5 | 2016 | 1284 | 0.170 |
Why?
|
Models, Theoretical | 1 | 2011 | 3580 | 0.160 |
Why?
|
Veterans | 1 | 2012 | 2672 | 0.150 |
Why?
|
Body Mass Index | 8 | 2017 | 13054 | 0.150 |
Why?
|
Cross-Sectional Studies | 11 | 2023 | 26384 | 0.150 |
Why?
|
Proprioception | 1 | 2019 | 134 | 0.150 |
Why?
|
Prospective Studies | 12 | 2023 | 54950 | 0.150 |
Why?
|
Central Nervous System Stimulants | 1 | 2006 | 1182 | 0.150 |
Why?
|
Anti-Infective Agents | 2 | 1996 | 984 | 0.150 |
Why?
|
Cognition | 5 | 2024 | 7080 | 0.150 |
Why?
|
Snoring | 1 | 2018 | 211 | 0.140 |
Why?
|
Ataxia | 1 | 2019 | 307 | 0.140 |
Why?
|
Prevalence | 7 | 2023 | 15875 | 0.130 |
Why?
|
Electromyography | 3 | 2023 | 1402 | 0.130 |
Why?
|
Medicare | 1 | 2014 | 6888 | 0.130 |
Why?
|
Excitatory Amino Acids | 1 | 1995 | 17 | 0.130 |
Why?
|
Ofloxacin | 1 | 1996 | 66 | 0.130 |
Why?
|
Carbon Radioisotopes | 1 | 2017 | 567 | 0.130 |
Why?
|
Aging | 4 | 2020 | 8765 | 0.120 |
Why?
|
Airway Resistance | 2 | 2007 | 407 | 0.120 |
Why?
|
Receptors, Glutamate | 1 | 1995 | 229 | 0.120 |
Why?
|
Cognition Disorders | 1 | 2009 | 3985 | 0.120 |
Why?
|
Attention | 4 | 2017 | 2425 | 0.120 |
Why?
|
Laryngoplasty | 1 | 2015 | 53 | 0.120 |
Why?
|
Reflex, Abnormal | 1 | 1994 | 83 | 0.110 |
Why?
|
Alopecia | 1 | 2018 | 416 | 0.110 |
Why?
|
Blinking | 1 | 1994 | 135 | 0.110 |
Why?
|
Cohort Studies | 9 | 2023 | 41800 | 0.110 |
Why?
|
Labyrinth Diseases | 1 | 1994 | 151 | 0.110 |
Why?
|
Gyrus Cinguli | 1 | 2019 | 1136 | 0.110 |
Why?
|
Tourette Syndrome | 1 | 1996 | 400 | 0.100 |
Why?
|
Intensive Care Units | 2 | 2023 | 3800 | 0.100 |
Why?
|
Independent Living | 1 | 2017 | 584 | 0.100 |
Why?
|
Nerve Net | 1 | 2024 | 2361 | 0.100 |
Why?
|
Epidemiologic Methods | 1 | 2017 | 1328 | 0.100 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2005 | 3411 | 0.100 |
Why?
|
Supine Position | 1 | 2012 | 208 | 0.100 |
Why?
|
Pulmonary Veins | 1 | 2017 | 758 | 0.100 |
Why?
|
Computational Biology | 1 | 2003 | 3562 | 0.090 |
Why?
|
Alzheimer Disease | 2 | 2023 | 8758 | 0.090 |
Why?
|
Aniline Compounds | 1 | 2017 | 1094 | 0.090 |
Why?
|
Neurologic Examination | 1 | 1994 | 916 | 0.090 |
Why?
|
Treatment Outcome | 6 | 2018 | 65485 | 0.090 |
Why?
|
Apolipoproteins E | 1 | 2017 | 1461 | 0.090 |
Why?
|
Policy Making | 1 | 2014 | 546 | 0.090 |
Why?
|
China | 1 | 2017 | 2395 | 0.090 |
Why?
|
Adenoidectomy | 1 | 2012 | 170 | 0.090 |
Why?
|
Sex Factors | 5 | 2018 | 10641 | 0.090 |
Why?
|
Accidents, Traffic | 1 | 2016 | 819 | 0.090 |
Why?
|
Comorbidity | 2 | 2019 | 10591 | 0.090 |
Why?
|
Automation | 1 | 2013 | 589 | 0.090 |
Why?
|
Atrial Fibrillation | 2 | 2020 | 5176 | 0.090 |
Why?
|
Telomere | 1 | 2016 | 943 | 0.090 |
Why?
|
Blood Gas Analysis | 1 | 2010 | 384 | 0.080 |
Why?
|
Autonomic Nervous System | 1 | 2014 | 709 | 0.080 |
Why?
|
Respiratory System Abnormalities | 1 | 2010 | 67 | 0.080 |
Why?
|
Thiazoles | 1 | 2017 | 1542 | 0.080 |
Why?
|
Electrooculography | 1 | 2009 | 113 | 0.080 |
Why?
|
Chin | 1 | 2009 | 38 | 0.080 |
Why?
|
Monitoring, Physiologic | 3 | 2015 | 1796 | 0.080 |
Why?
|
Tonsillectomy | 1 | 2012 | 280 | 0.080 |
Why?
|
Cell Count | 1 | 2013 | 1833 | 0.080 |
Why?
|
Glucose Tolerance Test | 1 | 2012 | 1183 | 0.080 |
Why?
|
Needs Assessment | 1 | 2014 | 1142 | 0.080 |
Why?
|
Self Report | 2 | 2017 | 3773 | 0.080 |
Why?
|
Population Surveillance | 1 | 2019 | 2597 | 0.080 |
Why?
|
Time Factors | 8 | 2018 | 40266 | 0.080 |
Why?
|
Masks | 1 | 2010 | 214 | 0.080 |
Why?
|
Oxygen | 2 | 2021 | 4273 | 0.070 |
Why?
|
Rats | 1 | 2024 | 23847 | 0.070 |
Why?
|
Retrospective Studies | 8 | 2020 | 81892 | 0.070 |
Why?
|
Brain Injuries | 1 | 2019 | 2058 | 0.070 |
Why?
|
Mandible | 1 | 2012 | 759 | 0.070 |
Why?
|
Age Factors | 5 | 2017 | 18454 | 0.070 |
Why?
|
Nervous System Diseases | 2 | 1995 | 1665 | 0.070 |
Why?
|
Data Display | 1 | 2007 | 174 | 0.070 |
Why?
|
Acclimatization | 1 | 2007 | 113 | 0.070 |
Why?
|
Anticonvulsants | 1 | 1997 | 1924 | 0.070 |
Why?
|
Leukocytes | 1 | 2015 | 2034 | 0.070 |
Why?
|
Reaction Time | 2 | 2013 | 2102 | 0.070 |
Why?
|
Databases, Factual | 2 | 2013 | 8095 | 0.070 |
Why?
|
Geriatric Assessment | 1 | 1994 | 1422 | 0.070 |
Why?
|
Body Weight | 1 | 2017 | 4628 | 0.070 |
Why?
|
Double-Blind Method | 2 | 2014 | 12469 | 0.070 |
Why?
|
Life Style | 1 | 2018 | 3931 | 0.070 |
Why?
|
Bacterial Infections | 1 | 1994 | 1397 | 0.070 |
Why?
|
Reference Values | 2 | 2017 | 4941 | 0.070 |
Why?
|
Probability | 1 | 2011 | 2483 | 0.060 |
Why?
|
Logistic Models | 4 | 2016 | 13317 | 0.060 |
Why?
|
Computer Graphics | 1 | 2007 | 344 | 0.060 |
Why?
|
Odds Ratio | 3 | 2017 | 9682 | 0.060 |
Why?
|
Theophylline | 1 | 2005 | 133 | 0.060 |
Why?
|
Frontal Lobe | 2 | 2017 | 1428 | 0.060 |
Why?
|
Prostheses and Implants | 1 | 2012 | 1279 | 0.060 |
Why?
|
Dominance, Cerebral | 1 | 2006 | 624 | 0.060 |
Why?
|
Algorithms | 3 | 2011 | 14199 | 0.060 |
Why?
|
Stroke Volume | 1 | 2019 | 5621 | 0.060 |
Why?
|
Respiratory Physiological Phenomena | 1 | 2006 | 192 | 0.060 |
Why?
|
Blood Gas Monitoring, Transcutaneous | 1 | 2005 | 34 | 0.060 |
Why?
|
Analysis of Variance | 2 | 2012 | 6242 | 0.060 |
Why?
|
Verbal Learning | 1 | 2006 | 465 | 0.060 |
Why?
|
Cardiovascular Physiological Phenomena | 1 | 2006 | 241 | 0.060 |
Why?
|
Genome, Human | 1 | 2017 | 4456 | 0.060 |
Why?
|
Seizures | 1 | 1997 | 3000 | 0.060 |
Why?
|
Age Distribution | 1 | 2009 | 2875 | 0.050 |
Why?
|
Longitudinal Studies | 4 | 2018 | 14795 | 0.050 |
Why?
|
Models, Biological | 2 | 2013 | 9499 | 0.050 |
Why?
|
Sympathetic Nervous System | 1 | 2006 | 521 | 0.050 |
Why?
|
Quality of Life | 3 | 2017 | 13510 | 0.050 |
Why?
|
Societies, Medical | 1 | 2014 | 3967 | 0.050 |
Why?
|
Blood Pressure | 2 | 2016 | 8541 | 0.050 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2017 | 3253 | 0.050 |
Why?
|
Health Policy | 1 | 2014 | 2700 | 0.050 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2014 | 1891 | 0.050 |
Why?
|
Rectal Neoplasms | 1 | 2011 | 1183 | 0.050 |
Why?
|
Psychometrics | 1 | 2011 | 3066 | 0.050 |
Why?
|
Epilepsy | 1 | 1997 | 3326 | 0.050 |
Why?
|
Muscle, Skeletal | 2 | 2009 | 4980 | 0.050 |
Why?
|
Hospitals, Urban | 1 | 2023 | 499 | 0.050 |
Why?
|
Research Design | 1 | 2017 | 6213 | 0.050 |
Why?
|
Noise | 1 | 2023 | 295 | 0.040 |
Why?
|
Demography | 1 | 2005 | 1643 | 0.040 |
Why?
|
Problem Solving | 1 | 2023 | 443 | 0.040 |
Why?
|
Memory Disorders | 1 | 2007 | 1203 | 0.040 |
Why?
|
Positron-Emission Tomography | 1 | 2017 | 6673 | 0.040 |
Why?
|
Homeostasis | 2 | 2015 | 3348 | 0.040 |
Why?
|
Exercise Test | 1 | 2007 | 2187 | 0.040 |
Why?
|
Combined Modality Therapy | 2 | 2011 | 8559 | 0.040 |
Why?
|
Health Surveys | 1 | 2009 | 4055 | 0.040 |
Why?
|
Diagnosis, Differential | 2 | 2009 | 13020 | 0.040 |
Why?
|
Mood Disorders | 1 | 2005 | 1129 | 0.040 |
Why?
|
Evoked Potentials | 1 | 2005 | 1058 | 0.040 |
Why?
|
Sensitivity and Specificity | 2 | 2011 | 14751 | 0.040 |
Why?
|
Adolescent | 3 | 2019 | 89247 | 0.040 |
Why?
|
Medical Records | 1 | 2004 | 1411 | 0.040 |
Why?
|
Gene Expression Profiling | 2 | 2012 | 9549 | 0.040 |
Why?
|
Pilot Projects | 2 | 2009 | 8742 | 0.040 |
Why?
|
Genetic Markers | 2 | 2016 | 2604 | 0.040 |
Why?
|
Computer Simulation | 1 | 2011 | 6289 | 0.040 |
Why?
|
Korea | 1 | 2017 | 97 | 0.040 |
Why?
|
Heart Diseases | 1 | 2010 | 2819 | 0.030 |
Why?
|
Cell Proliferation | 1 | 2013 | 10486 | 0.030 |
Why?
|
Risk Factors | 7 | 2018 | 74971 | 0.030 |
Why?
|
Habits | 1 | 2017 | 148 | 0.030 |
Why?
|
Anisotropy | 1 | 2019 | 1295 | 0.030 |
Why?
|
Entropy | 1 | 2016 | 211 | 0.030 |
Why?
|
Aged, 80 and over | 4 | 2020 | 59738 | 0.030 |
Why?
|
Animals | 3 | 2024 | 169408 | 0.030 |
Why?
|
Longevity | 1 | 2023 | 1077 | 0.030 |
Why?
|
Lung Diseases, Obstructive | 1 | 1996 | 311 | 0.030 |
Why?
|
Obesity | 1 | 2017 | 13087 | 0.030 |
Why?
|
HIV Infections | 1 | 2021 | 17589 | 0.030 |
Why?
|
Electrophysiologic Techniques, Cardiac | 1 | 2017 | 511 | 0.030 |
Why?
|
United States | 3 | 2023 | 73180 | 0.030 |
Why?
|
Young Adult | 3 | 2019 | 60110 | 0.030 |
Why?
|
Delta Rhythm | 1 | 2015 | 82 | 0.030 |
Why?
|
Epidemiologic Studies | 1 | 2017 | 677 | 0.030 |
Why?
|
Cell Aggregation | 1 | 2014 | 238 | 0.030 |
Why?
|
Adenocarcinoma | 1 | 2011 | 6401 | 0.030 |
Why?
|
Atrophy | 1 | 2018 | 1647 | 0.030 |
Why?
|
Still's Disease, Adult-Onset | 1 | 1992 | 23 | 0.020 |
Why?
|
Chronic Disease | 1 | 2007 | 9384 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2012 | 16051 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 2 | 2012 | 18065 | 0.020 |
Why?
|
Culture Media | 1 | 2014 | 898 | 0.020 |
Why?
|
Child, Preschool | 2 | 2012 | 42684 | 0.020 |
Why?
|
Syndrome | 1 | 2017 | 3274 | 0.020 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2006 | 3743 | 0.020 |
Why?
|
Creatinine | 1 | 2016 | 1917 | 0.020 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 1995 | 905 | 0.020 |
Why?
|
Action Potentials | 1 | 2017 | 1838 | 0.020 |
Why?
|
Biomarkers, Pharmacological | 1 | 2011 | 162 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2011 | 11886 | 0.020 |
Why?
|
Ohio | 1 | 2010 | 321 | 0.020 |
Why?
|
Child | 3 | 2012 | 80969 | 0.020 |
Why?
|
Follow-Up Studies | 3 | 2017 | 39394 | 0.020 |
Why?
|
Diffusion Tensor Imaging | 1 | 2019 | 2426 | 0.020 |
Why?
|
Executive Function | 1 | 2017 | 1405 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2015 | 2359 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2011 | 755 | 0.020 |
Why?
|
Language | 1 | 2017 | 1559 | 0.020 |
Why?
|
Regression Analysis | 1 | 2017 | 6346 | 0.020 |
Why?
|
Premenopause | 1 | 2012 | 1039 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2017 | 6856 | 0.020 |
Why?
|
Robotics | 1 | 2014 | 826 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2017 | 6546 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2014 | 2635 | 0.020 |
Why?
|
Disease Progression | 1 | 2023 | 13677 | 0.020 |
Why?
|
Overweight | 1 | 2017 | 2445 | 0.020 |
Why?
|
Postoperative Care | 1 | 2012 | 1481 | 0.020 |
Why?
|
Equipment Design | 1 | 2014 | 3529 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2012 | 3438 | 0.020 |
Why?
|
Risk | 1 | 2017 | 9621 | 0.020 |
Why?
|
Alcohol Drinking | 1 | 2018 | 4045 | 0.020 |
Why?
|
Recurrence | 1 | 2017 | 8512 | 0.020 |
Why?
|
Linear Models | 1 | 2015 | 5890 | 0.010 |
Why?
|
Massachusetts | 1 | 2017 | 8888 | 0.010 |
Why?
|
Catheter Ablation | 1 | 2017 | 2780 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2017 | 12093 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2012 | 3811 | 0.010 |
Why?
|
Preoperative Care | 1 | 2012 | 2258 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2020 | 22294 | 0.010 |
Why?
|
Exercise | 1 | 2018 | 5953 | 0.010 |
Why?
|
Smoking | 1 | 2018 | 9094 | 0.010 |
Why?
|
Gene Expression | 1 | 2014 | 7602 | 0.010 |
Why?
|
Risk Assessment | 2 | 2012 | 24330 | 0.010 |
Why?
|
Prognosis | 2 | 2011 | 30044 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2018 | 5892 | 0.010 |
Why?
|
Parkinson Disease | 1 | 1994 | 2896 | 0.010 |
Why?
|
Cell Line | 1 | 2014 | 15603 | 0.010 |
Why?
|
Observer Variation | 1 | 2006 | 2623 | 0.010 |
Why?
|
Neoadjuvant Therapy | 1 | 2011 | 2909 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2012 | 12563 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2014 | 11684 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2011 | 8664 | 0.010 |
Why?
|
Mental Disorders | 1 | 1994 | 6879 | 0.010 |
Why?
|
Phenotype | 1 | 2012 | 16735 | 0.010 |
Why?
|
Incidence | 1 | 2012 | 21545 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2012 | 12798 | 0.010 |
Why?
|
Joint Diseases | 1 | 1992 | 461 | 0.000 |
Why?
|
Vasculitis | 1 | 1992 | 525 | 0.000 |
Why?
|
Eye Diseases | 1 | 1992 | 658 | 0.000 |
Why?
|
India | 1 | 1992 | 2325 | 0.000 |
Why?
|
Liver Diseases | 1 | 1992 | 1305 | 0.000 |
Why?
|